IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Protalix Biotherapeutics Inc

CUSIP: 74365AAB7 | 13 institutional holders

Quarters

Q2 2018Q1 2018Q4 2017Q3 2017Q2 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2018

Dafna Capital Management LLC2,500,000
0.0% of portfolio›$2.4K
StyleTurnoverLocationFiled
Dafna Capital Management LLC
2,500,000$2.4K0.0%ValueMediumLos Angeles, CA2018-08-13